Drug Development Technology is using cookies

We use them to give you the best experience. If you continue using our website, we'll assume that you are happy to receive all cookies on this website.

ContinueLearn More X
X

Hemlibra® (emicizumab-kxwh) for the Treatment of Haemophilia A with Inhibitors

Drug (Brand/Generic)

Hemlibra®/emicizumab-kxwh

Company

Genentech, a member of the Roche Group

Therapy Class

Antibodies

Current Indication

Haemophilia A with inhibitors

Market Sector

Genetics

Development Status

Approved in the US, MAA under review by EMA
Expand

Go Top